TY - JOUR
T1 - Biomimetic models of the glomerulus
AU - Valverde, Marta G.
AU - Mille, Luis S.
AU - Figler, Kianti P.
AU - Cervantes, Ernesto
AU - Li, Vanessa Y.
AU - Bonventre, Joseph V.
AU - Masereeuw, Rosalinde
AU - Zhang, Yu Shrike
N1 - Funding Information:
The authors gratefully acknowledge research funding from the National Institutes of Health (R00CA201603, R21EB025270, R21EB026175, R21EB030257, R01EB028143, R01HL153857, R01DK72381, R03EB027984, R37DK39773 and UH3TR002155), the National Science Foundation (CBET-EBMS-1936105), the Brigham Research Institute, the Hofvijverkring Visiting Scientist Program, the Dutch Kidney Foundation (18KVP01), Utrecht Institute for Pharmaceutical Sciences and European Union’s Horizon 2020 research and innovation programme WIDESPREAD-05-2018-TWINNING Remodel.
Publisher Copyright:
© 2022, Springer Nature Limited.
PY - 2022/4
Y1 - 2022/4
N2 - The use of biomimetic models of the glomerulus has the potential to improve our understanding of the pathogenesis of kidney diseases and to enable progress in therapeutics. Current in vitro models comprise organ-on-a-chip, scaffold-based and organoid approaches. Glomerulus-on-a-chip designs mimic components of glomerular microfluidic flow but lack the inherent complexity of the glomerular filtration barrier. Scaffold-based 3D culture systems and organoids provide greater microenvironmental complexity but do not replicate fluid flows and dynamic responses to fluidic stimuli. As the available models do not accurately model the structure or filtration function of the glomerulus, their applications are limited. An optimal approach to glomerular modelling is yet to be developed, but the field will probably benefit from advances in biofabrication techniques. In particular, 3D bioprinting technologies could enable the fabrication of constructs that recapitulate the complex structure of the glomerulus and the glomerular filtration barrier. The next generation of in vitro glomerular models must be suitable for high(er)-content or/and high(er)-throughput screening to enable continuous and systematic monitoring. Moreover, coupling of glomerular or kidney models with those of other organs is a promising approach to enable modelling of partial or full-body responses to drugs and prediction of therapeutic outcomes.
AB - The use of biomimetic models of the glomerulus has the potential to improve our understanding of the pathogenesis of kidney diseases and to enable progress in therapeutics. Current in vitro models comprise organ-on-a-chip, scaffold-based and organoid approaches. Glomerulus-on-a-chip designs mimic components of glomerular microfluidic flow but lack the inherent complexity of the glomerular filtration barrier. Scaffold-based 3D culture systems and organoids provide greater microenvironmental complexity but do not replicate fluid flows and dynamic responses to fluidic stimuli. As the available models do not accurately model the structure or filtration function of the glomerulus, their applications are limited. An optimal approach to glomerular modelling is yet to be developed, but the field will probably benefit from advances in biofabrication techniques. In particular, 3D bioprinting technologies could enable the fabrication of constructs that recapitulate the complex structure of the glomerulus and the glomerular filtration barrier. The next generation of in vitro glomerular models must be suitable for high(er)-content or/and high(er)-throughput screening to enable continuous and systematic monitoring. Moreover, coupling of glomerular or kidney models with those of other organs is a promising approach to enable modelling of partial or full-body responses to drugs and prediction of therapeutic outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85123234946&partnerID=8YFLogxK
U2 - 10.1038/s41581-021-00528-x
DO - 10.1038/s41581-021-00528-x
M3 - Review article
SN - 1759-5061
VL - 18
SP - 241
EP - 257
JO - Nature Reviews Nephrology
JF - Nature Reviews Nephrology
IS - 4
ER -